A new study debunks the “obesity paradox,” a counterintuitive finding that people with cardiovascular disease live longer if they are overweight or obese.
A simple toolkit of checklists, education materials and feedback reporting improved the quality of care, but not outcomes, in a group of 60 hospitals in south India, according to a new Northwestern Medicine study.
At Keep Your Heart Healthy events, Feinberg medical students provide cardiovascular disease risk assessment and prevention counseling to underserved communities.
The previously unknown cause of anti-phosphatidylethanolamine (aPE) autoimmunity was discovered in a Northwestern Medicine study published in PNAS.
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
A newly announced American Heart Association research center will be led by Mary McDermott, MD, and focus on calf muscle pathology in peripheral artery disease.
Scientists are one step closer to a stem cell treatment for muscular dystrophy after Northwestern Medicine investigators demonstrated improvements in muscle tissue differentiation in stem cells.
A newly discovered gene mutation may increase a patient’s risk of genetic heart disease, presenting a target for therapy or genetic screening down the road.
Northwestern Medicine scientists have demonstrated the potential of targeting inflammatory pathways in order to limit tissue damage and improve repair after a heart attack.
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.